Gilead Sciences: Pharmaceutical Prices, Patents, And The FDA

Gilead Sciences: Pharmaceutical Prices, Patents, And The FDA by Timothy D. Terrell, Mises Institute

In this article by economist Jeffrey Sachs, pharmaceutical company Gilead is taken to task for selling its hepatitis C cure, Sofosbuvir (sold as Sovaldi), at a price of $84,000 per course of treatment. Sachs says that the actual production cost of Sofosbuvir is about $100.

Sachs says that Gilead is "bilking the taxpayer" by charging the government prices far above production costs — and...

What feeling does this article give you?
Joy
Disgust
Fear
Anger
Sadness

#hashtags to follow:

Gilead Sciences [+]    Pharmaceutical Prices [+]    Patents [+]    FDA [+]    Timothy [+]    Mises Institute [+]    Jeffrey Sachs [+]    Gilead [+]    Sofosbuvir [+]    Sovaldi [+]    Sachs [+]   

More #news: